miRagen Therapeutics, Inc. announced that it has appointed biotechnology industry veteran Arlene Morris to the role of independent board member on its board of directors, effective January 3, 2018. Ms. Morris currently serves as Chief Executive Officer at Willow Advisors, LLC, a consultancy advising biotech companies on financing, strategy and business development.